This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Viravaxx Ag. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Daniela Gallerano: Innovator in HIV Detection
Introduction
Daniela Gallerano is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical diagnostics, particularly in the detection of HIV. With a total of 2 patents to her name, her work is vital in advancing healthcare technologies.
Latest Patents
Gallerano's latest patents include a method for detecting HIV-1-specific antibodies using clade C env polypeptides. This invention relates to a method for detecting and quantifying human immunodeficiency virus (HIV) specific antibodies in a sample. The method involves determining the presence and amount of antibodies binding to specific peptides. Another notable patent is for a solid support comprising HIV-1 clade C envelope peptides for the detection of HIV-1-specific antibodies. This invention also focuses on the detection and quantification of HIV-specific antibodies in samples.
Career Highlights
Gallerano is currently associated with Viravaxx AG, a company dedicated to innovative solutions in the field of immunology. Her work at Viravaxx AG has positioned her as a key player in the development of advanced diagnostic methods.
Collaborations
Throughout her career, Gallerano has collaborated with notable professionals in her field, including Rudolf Valenta and Elopy N Sibanda. These collaborations have further enhanced her research and contributions to HIV detection technologies.
Conclusion
Daniela Gallerano's innovative work in the detection of HIV has made a significant impact on medical diagnostics. Her patents reflect her commitment to improving healthcare outcomes through advanced technology.